Blog

Founders on Reddit have stopped asking which platform has the best features and started asking who owns the patient, the records, the card tokens, the pharmacy contract, and the domain when the relationship ends. Those are the right questions, and most sales pages do not answer them. Here are the five ownership dimensions, what each model gives you, the contract language to demand, and where Turbopills stands.

The telehealth platforms are now pitching pharmacies directly ('add virtual care programs to your pharmacy, no extra staff'), and a compounding pharmacy's own trade press warns that clinics without exclusive pharmacy partnerships 'face attrition to CVS, Amazon Pharmacy, and telehealth platforms.' A pharmacy that has watched a third of its GLP-1 volume disappear with the shortage has a choice: rent patients from a platform, sign exclusivity with clinics, or put its own brand on a front end and keep the patient. Here is what the third option requires, from the clinical entity to the storefront, and where the lines are.

Since April 1, 2026, a merchant whose fraud reports plus disputes exceed 1.5% of settled card-not-present transactions is 'excessive' under Visa's Acquirer Monitoring Program, pays $8 per disputed or fraudulent transaction, and becomes a problem for an acquirer that already treats telehealth as a restricted category. For a 500-patient subscription program that is seven bad transactions in a month. Here is how the ratio is counted, where telehealth disputes actually come from, and the billing settings that keep a program under the line.

The pages that rank for 'telehealth CRM' were written in 2022 and 2023 and recommend Salesforce, Zoho and Zendesk to everyone. A DTC telehealth brand has a narrower problem: it needs a system that knows a patient's clinical state, holds protected health information legally, and runs the five workflows that decide conversion and retention, without turning the marketing tool into a medical record. Here are the five realistic options, what each costs in 2026, the test that generic CRMs fail, and what to use at each stage.

On July 29, 2026 the FTC, Utah and Los Angeles County sued Hims & Hers over three things every DTC telehealth brand does or has been tempted to do: charging at intake before a provider has looked at the case, hiding the cancel button, and sending patient events to Meta and Snap. Hims says the claims are baseless and will fight them. Whatever the court decides, the complaint is the clearest checkout specification the category has ever been handed. Here is the spec.

Between September and November, millions of people decide how much pre-tax money to set aside for 2027. A patient who knows your program takes HSA and FSA dollars sizes their election with you in mind; one who finds out in February does not. This is the implementation layer under the strategy: what is eligible with a prescription, what needs a Letter of Medical Necessity, why cards decline, what a clean receipt contains, and how to configure subscriptions so the medical portion survives a claims review.

GLP-1 medication errors are exploding in FDA data, adverse-event counts tied to compounded semaglutide and tirzepatide keep climbing, and FDA warning letters have hit telehealth marketing twice this year. Regulators are now reading DTC programs through a safety lens, and so are patients. The programs that treat side-effect triage as core infrastructure, not a support afterthought, will churn less, spend less on support, and look better in every review and AI answer written about them. Here is how to build that layer.

The medical director is the one hire that gates your launch date, your state map, and your legal structure, and there is no hiring guide for it. Here is where to actually find one, the three compensation models that work, ten interview questions with teeth, and the red flags that should end the conversation.

Ask five founders how much it costs to start a telehealth business and you will get five numbers between $20,000 and half a million, all correct. The variance is not mystery, it is one decision: how much of the stack you assemble yourself. Here is the full line-item budget with real ranges, the self-assembly pile that platforms like Turbopills make disappear, and three worked scenarios from bootstrap single-state to 50 states.

Somewhere in the last year, clinical governance quietly changed jobs. It used to be the thing operators built reluctantly, a cost of doing business. Now it is the thing that wins enterprise partnerships, retail marketplace listings, benefits-consultant referrals, and acquisition interest, because every serious counterparty in telehealth has learned to check. The brands treating governance as a sales asset are closing deals the others never hear about. Here is the reframe, and the build.

Over the next three weeks, the public telehealth companies report Q2, and for one brief window a year, private operators get audited numbers from businesses running the same playbook. Most founders skim the headlines. The better move is structured listening: five metrics, pulled from every call, translated into your own dashboard. Here is the guide, with the questions to ask of each number.

Payment processors look harder at telehealth than at almost any other online business, and the operators who understand what underwriting actually checks sail through review while unprepared competitors stall. This is the playbook for building payments infrastructure that gets approved and stays approved: the documentation pack, the entity alignment, the descriptor and refund hygiene, and the redundancy that makes payouts boring in the best possible way.

Multi-state licensure used to be the slowest part of telehealth expansion. In 2026 it is a momentum game: the Interstate Medical Licensure Compact now covers 44 states plus DC and Guam, nursing and psychology compacts keep widening, and compact-route licenses issue in weeks instead of months. This is the operator's strategy guide: how compacts actually work, how to sequence states for compounding coverage, and how licensure-aware infrastructure turns a licensing wall into a rollout schedule.

Ask how telehealth companies handle pharmacy and most answers come from pharmacies selling fulfillment. The platform-side view, how prescriptions actually get routed, what happens when a pharmacy fails, how branded and compounded rails coexist, and what the patient sees throughout, is the operational layer that separates smooth programs from support-ticket factories. This is the architecture guide.

Search for weight loss clinic software and you get practice-management suites built for in-person clinics (PatientNow, Remedly, Zenoti, Mangomint) and consumer GLP-1 programs marketing to patients. Neither is what a cash-pay GLP-1 program running online needs. This is the operator-side answer: the requirements list from intake through refill, the suites compared with an infrastructure platform, the September 2026 price context ($29 CVS visits, $149-$349 branded drugs, a $50 Medicare Bridge), and how to evaluate what you buy.

The build-vs-buy question is the first infrastructure decision every telehealth founder makes, and the answer changed in 2026. Tiny teams are launching national telehealth brands by treating every dependency as a service instead of a hire: licensed providers, pharmacy fulfillment, compliance scaffolding, and the platform itself. This is the honest decision framework for founders weighing a custom build against modern white-label infrastructure.

Every telehealth platform claims HIPAA compliance. The difference between a vendor that actually meets the standard and one that uses the label as marketing is large and consequential. This is the operator's guide to what HIPAA-compliant telehealth software actually means in 2026: the rules, the safeguards, the contractual structure, and the questions that separate substance from marketing.

Most DTC telehealth brands migrate platforms at least once. The right migration carries the patient relationship across the change without disruption. The wrong one costs months of patient experience, provider time, and revenue. This is the operator's playbook for switching telehealth vendors with confidence: when to migrate, what to plan, how to sequence the work, and how to land the new platform without breaking patient care.

A white-label telehealth platform decision in 2026 is one of the highest-switching-cost choices a DTC founder makes. The platform shapes everything: time to launch, patient experience, provider workflow, compliance posture, and how fast the brand can grow into new states and programs. This is the operator's evaluation framework: the 15 dimensions that matter, the scoring pattern, the trial that beats the demo, and the contract terms that earn the platform its place.

The best EHR for a DTC telehealth brand depends on the program profile: Healthie for cash-pay launches (its price list runs $19 to $149+ a month as of September 2026), Elation for virtual primary care, athenaOne for payer billing, Canvas for teams that build. This is an operator-honest comparison across charting depth, API maturity, billing, pharmacy and lab integrations, and white-label fit, plus a scoring framework for your own shortlist and a section on when an all-in-one platform means you do not need a separate EHR at all.